UNDERSTANDING HIV/AIDS: Overview and Life Cycle !

What is HIV/AIDS?

HIV stands for human immunodeficiency virus, which is the virus that causes HIV infection. The abbreviation “HIV” can refer to the virus or to HIV infection.

AIDS stands for acquired immunodeficiency syndrome. AIDS is the most advanced stage of HIV infection.

HIV attacks and destroys the infection-fighting CD4 cells of the immune system. The loss of CD4 cells makes it difficult for the body to fight infections and certain cancers. Without treatment, HIV can gradually destroy the immune system and advance to AIDS.

How is HIV spread?

HIV is spread through contact with certain body fluids from a person with HIV. These body fluids include:

• Blood
• Semen
• Pre-seminal fluid
• Vaginal fluids
• Rectal fluids
• Breast milk

The spread of HIV from person to person is called HIV transmission. The spread of HIV from a woman with HIV to her child during pregnancy, childbirth, or breastfeeding is called mother-to-child transmission of HIV.

In the United States, HIV is spread mainly by having sex with or sharing drug injection equipment with someone who has HIV. To reduce your risk of HIV infection, use condoms correctly and consistently during sex, limit your number of sexual partners, and never share drug injection equipment. 

Mother-to-child transmission is the most common way that children become infected with HIV. HIV medicines, given to women with HIV during pregnancy and childbirth and to their babies after birth, reduce the risk of mother-to-child transmission of HIV. 

You can’t get HIV by shaking hands or hugging a person who has HIV. You also can’t get HIV from contact with objects such as dishes, toilet seats, or doorknobs used by a person with HIV. HIV does not spread through the air or through mosquito, tick, or other insect bites.

The HIV Life Cycle

HIV attacks and destroys the CD4 cells of the immune system. CD4 cells are a type of white blood cell that play a major role in protecting the body from infection. HIV uses the machinery of the CD4 cells to multiply (make copies of itself) and spread throughout the body. This process, which is carried out in seven steps or stages, is called the HIV life cycle.

What is the connection between the HIV life cycle and HIV medicines?

Antiretroviral therapy (ART) is the use of HIV medicines to treat HIV infection. HIV medicines protect the immune system by blocking HIV at different stages of the HIV life cycle.

HIV medicines are grouped into different drug classes according to how they fight HIV. Each class of drugs is designed to target a specific step in the HIV life cycle.

ART combines HIV medicines from at least two different HIV drug classes, making it very effective at preventing HIV from multiplying. Having less HIV in the body protects the immune system and prevents HIV from advancing to AIDS. ART also reduces the risk of HIV drug resistance.

ART can’t cure HIV, but HIV medicines help people with HIV live longer, healthier lives. HIV medicines also reduce the risk of HIV transmission (the spread of HIV to others).

What are the seven stages of the HIV life cycle?

The seven stages of the HIV life cycle are: 1) binding, 2) fusion, 3) reverse transcription, 4) integration, 5) replication, 6) assembly, and 7) budding. To understand each stage in the HIV life cycle, it helps to first imagine what HIV looks like.

Now follow each stage in the HIV life cycle, as HIV attacks a CD4 cell and uses the machinery of the cell to multiply.

Read more: HIV Overview

Video: The Life Cycle of HIV

This video explains how HIV targets human immune cells, and uses immune cell machinery to make copies of itself. By comparing an analogy to the life cycle of HIV, this presentation will help you understand how HIV systematically reduces immunity within the body.

Source: YouTube

Association Between Genetic Variation And Influenza Severity.

It is estimated that in the USA influenza -related deaths in recent years have ranged from 12,000 to 56,000. Factors like age, obesity, pregnancy and such chronic health conditions as asthma, chronic lung disease and heart disease are associated with an elevated risk of complications and death.

However, there are no proven genetic markers of influenza risk with an established mechanism of action. Interferon Induced Transmembrane Protein 3 (IFITM3) is an anti-viral protein that helps to block influenza infection of lung cells and to promote survival of the killer T cells that help clear the infection in the airways.

Image: A scanning electron micrograph of a CD8+ T cell engaging a virus.

(Photo courtesy of Dennis Kunkel).

A group of scientists collaborating with those at St. Jude Children's Research Hospital (Memphis, TN, USA) searched for other possible IFITM3 variants that correlated with gene expression, levels of the IFITM3 proteins and were common in influenza patients in the USA. The search led to an IFITM3 variant known as rs34481144. They checked 86 children and adults in Memphis with confirmed influenza infections and found two-thirds of patients with the most severe symptoms carried at least one copy of the newly identified high-risk IFITM3 variant. The high-risk variant was found in just 32% of patients with milder symptoms.

The team also found an association between the newly identified high-risk variant and severe and fatal influenza infections in 265 critically ill pediatric patients hospitalized in one of 31 intensive care units nationwide. The patients did not have health problems that put them at high risk for severe influenza. Of the 17 patients in this group who died from the infection, 14 carried at least one copy of the newly identified high-risk variant. Further study revealed how binding differed between the high-risk and protective variants. Those differences led to lower levels of the IFITM3 protein in individuals with two copies of the high-risk gene variant compared to other patients. The Memphis influenza patients also had fewer of the killer T cells in their upper airways. The study identifies a new regulator of IFITM3 expression that associates with CD8+ T cell levels in the airways and a spectrum of clinical outcomes.

Paul Thomas, PhD, an immunologist and corresponding author of the study, said, “A genetic marker of influenza risk could make a life-saving difference, particularly during severe influenza outbreaks, by helping prioritize high-risk patients for vaccination, drug therapy and other interventions. These results raise hopes that this newly identified IFITM3 variant might provide such a marker.” The study was published on July 17, 2017, in the journal Nature Medicine.

Source: labmedica

The Best Medicine Against Cholesterol And High Blood Pressure

Cholesterol is a waxy substance that comes from two sources: your body and food. Excess cholesterol can form plaque between layers of artery walls, making it harder for your heart to circulate blood.

Plaque can break open and cause blood clots. If a clot blocks an artery that feeds the brain, it causes a stroke. If it blocks an artery that feeds the heart, it causes a heart attack.

Heart disease, stroke and other cardiovascular diseases are among the leading cause of death and now kill more than 800,000 adults in the US each year. Two main reasons people have heart disease or stroke are high blood pressure and cholesterol.

Read more: The Best Medicine Against Cholesterol And High Blood Pressure

Source: herb-cookbook

Cure The Strep Throat in One Day Without Taking Antibiotics

Strep throat is a very common problem, driving countless individuals to see a doctor for antibiotic treatment. But as with virtually all other problems, no drugs are required for strep throat treatment. In fact, there are rather simple and natural solutions for staving off and treating a case of strep. 

Unfortunately, the medical establishment can’t have you recognizing these ridiculously simple solutions for the problem, however, as drug sales and subsequent profit would take a nosedive. To avoid pharmaceutical treatment, you must learn how to treat strep throat naturally yourself.

Read more: Cure The Strep Throat in One Day Without Taking Antibiotics

Source: healthylivingstyle

Pregnancy Rates Higher for Women Who Have Had Tonsils, Appendix Removed

New study has uncovered a surprising association, finding that the surgical removal of the appendix or tonsils in younger age may increase a woman's chance of pregnancy.

Study co-author Sami Shimi, clinical senior lecturer in the School of Medicine at the University of Dundee, United Kingdom, and colleagues say their findings - published in Fertility and Sterility - should ease concerns that such procedures may reduce a woman's fertility.

The surgical removal of the tonsils, known as a tonsillectomy, is normally carried out as a result of frequent infection or inflammation of the tonsils (tonsillitis) or sleep-disordered breathing.

Surgical removal of the appendix, called an appendectomy, is normally the first-line treatment when the organ becomes infected or swollen - a condition known as appendicitis.

Read more: Pregnancy Rates Higher for Women Who Have Had Tonsils, Appendix Removed

Women who underwent a tonsillectomy or appendectomy when younger
were found to have higher pregnancy rates in a new study.

Source: medicalnewstoday

Precision Medicine in Oncology

The White House Proposes Increased Funding For a National Precision Medicine Initiative

In his 2015 State of the Union address, President Obama stated his intention to fund a national Precision Medicine Initiative (PMI), defined by the NIH as an emerging approach for disease prevention and treatment that takes into account individual variations in genes, environment, and lifestyle.

The White House said that it will ask Congress for $215 million to fund the assembly of databases. Through the data, from over one million patients, scientists and researchers will be able to individualize care and generate the requisite scientific evidence to move the concept of precision medicine into clinical practice.

The initiative, in the near-term, focuses on cancer, with other disease areas included over the longer term. Of the $215 million, the White House proposed $70 million in increased funding for the NCI to advance the field of precision oncology.

Basically the initiative funds efforts to integrate and apply the explosion of molecular data on humans, particularly data associated with individual patients, and taps into opportunities to use it to improve health outcomes. The “time is right” for the initiative, NIH says, because of the sequencing of the human genome, improved technologies for biomedical analysis, and new tools for using large datasets.

Read more: Precision Medicine in Oncology

MATCH clinical trials analyze tumors for abnormalities using a targeted sequencing

assay that includes 143 genes selected using the Oncomine Knowledgebase.

Source: Deposit Photos/alexraths